May 9, 2012
Sanofi-aventis K.K. announced on May 7 that it has initiated a domestic PIII clinical trial of hydroxychloroquine sulfate in patients with systemic lupus erythematosus (SLE) and cutaneous lupus erythematosus (CLE). Since no clinical trials of the drug that comply with...read more